Table 3.
Comparison between control group and patient group for each parameter.
| Parameters | Groups | N | Min. | Max. | Mean ± S.D. | Median | Percent Change | p Value |
|---|---|---|---|---|---|---|---|---|
| Anti-mitochondrial antibodies (AMA-M2) | Control | 14 | 0.08 | 0.11 | 0.10 ± 0.01 | 0.10 | 100.00 | 0.050 |
| Patient | 54 | 0.08 | 0.33 | 0.22 ± 0.03 | 0.10 | 227.13 | ||
| Anti-histone antibodies | Control | 20 | 0.25 | 7.70 | 1.82 ± 1.84 | 1.15 | 100.00 | 0.001 |
| Patient | 45 | 0.05 | 8.13 | 0.87 ± 1.47 | 0.37 | 47.71 | ||
| PLA2/COX-2 | Control | 40 | 0.00 | 0.56 | 0.11 ± 0.13 | 0.07 | 100.00 | 0.001 |
| Patient | 40 | 0.00 | 3.07 | 0.62 ± 0.58 | 0.44 | 537.34 |